Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer

OBJECTIVES: This analysis investigated nomogram use to evaluate metastatic pancreatic cancer prognosis. METHODS: Thirty-four baseline factors were examined in the Metastatic Pancreatic Adenocarcinoma Clinical Trial (MPACT) (nab-paclitaxel plus gemcitabine vs gemcitabine) data set. Factors significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldstein, David, Von Hoff, Daniel D., Chiorean, E. Gabriela, Reni, Michele, Tabernero, Josep, Ramanathan, Ramesh K., Botteman, Marc, Aly, Abdalla, Margunato-Debay, Sandra, Lu, Brian, Louis, Chrystal U., McGovern, Desmond, Lee, Chee Khoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314499/
https://www.ncbi.nlm.nih.gov/pubmed/32541630
http://dx.doi.org/10.1097/MPA.0000000000001563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314499/
https://www.ncbi.nlm.nih.gov/pubmed/32541630
http://dx.doi.org/10.1097/MPA.0000000000001563

Ejemplares similares